Genetic aspects of thrombotic disease

Thrombosis and Haemostasis

Volumn 114, Issue 5, 2015, Pages 883-884

  de Frutos, Pablo García ^a   Zöller, Bengt ^b  

^a INST D INVESTIGACIONS B   (Spain)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; PROTHROMBIN; ANTITHROMBIN III; PLASMA PROTEIN; PROS1 PROTEIN, HUMAN; PROTEIN C; SERPINC1 PROTEIN, HUMAN;

ACTIVATED PROTEIN C RESISTANCE; ANTITHROMBIN DEFICIENCY; EDITORIAL; GENE MUTATION; HUMAN; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; THROMBOPHILIA; VEIN THROMBOSIS; FIBRINOLYSIS; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEMATOPOIESIS; MUTATION; PEDIGREE; RISK FACTOR;

ANTITHROMBIN III; BLOOD PROTEINS; FIBRINOLYSIS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEMATOPOIESIS; HUMANS; MUTATION; PEDIGREE; POLYMORPHISM, GENETIC; PROTEIN C; RISK FACTORS; THROMBOPHILIA;

EID: 84946568341     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-10-0774     Document Type: Editorial

References (17)

1. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516–530.
2. Thomas D. Gene--environment-wide association studies: emerging approaches. Nat Rev Genet 2010; 11: 259–272.
3. Miletich JP, Prescott SM, White R, et al. Inherited predisposition to thrombosis. Cell 1993; 72: 477–480.
4. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004–1008.
5. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–67.
6. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703.
7. Laffan M, Tuddenham E. Thrombophilia: an expanding group of genetic defects that predispose to thrombosis. Mol Med Today 1997; 3: 303–309.
8. Miletich JP. Thrombophilia as a multigenic disorder. Semin Thromb Hemost 1998; 24 (Suppl 1): 13–20.
9. Zöller B, García de Frutos P, Hillarp A, et al. Thrombophilia as a multigenic disease. Haematologica 1999; 84: 59–70.
10. Mannucci PM, Franchini M. Classic thrombophilic gene variants. Thromb Haemost 2015; 114: 885-889.
11. Zöller B, Li X, Ohlsson H, et al. Familial history of venous thromboembolism as a risk factor and genetic research tool. Thromb Haemost 2015; 114: 890-900.
12. Hirschhorn JN, Lohmueller K, Byrne E, et al. A comprehensive review of genetic association studies. Genet Med The American College of Medical Genetics; 2002; 4: 45–61.
13. Tang L, Hu Y. Ethnic diversity in the genetics of venous thromboembolism. Thromb Haemost 2015; 114: 901-909.
14. Souto JC, Pena G, Ziyatdinov A, et al. A genomewide study of body mass index and its genetic correlation with thromboembolic risk. Results from the GAIT project. Thromb Haemost 2014; 112: 1036–1043.
15. Dennis J, Kassam I, Morange P-E, et al. Genetic determinants of tissue factor pathway inhibitor plasma levels. Thromb Haemost 2015; 114: 245–257.
16. Morange P, Suchon P, Trégouët DA. Genetics of Venous Thrombosis: update in 2015. Thromb Haemost 2015; 114: 910-919.
17. Cunha MLR, Meijers JCM, Middeldorp S. Introduction to the analysis of next generation sequencing data and its application to venous thromboembolism. Thromb Haemost 2015; 114: 920-932.